Analysis: Longer Review Times Associated With Fewer Adverse Events for High-Risk Heart Devices

A new analysis finds longer regulatory review times for high-risk cardiovascular medical devices to be associated with fewer adverse event reports, and a lower likelihood of such reports citing serious injury or death.

 

The analysis, published in Nature Biomedical Engineering on Friday, raises questions about the trade-offs between speeding access to new devices and ensuring their safety.

 

Read the full article here.

Tags:

Please reload

Please reload

© 2016 by The National Center for Health Research. 

  • Facebook Clean
  • Twitter Clean